ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Baltimore, MD, USA:

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics (COV19-APTP-B)

that suggests the potential for clinical benefit of COVID-19 patients.1. Treat Infection of Multiple Gene Mutation COVID-19...

Active, not recruiting
Covid19
Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection

Early Phase 1

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

North Bethesda, Maryland, United States

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 123 other locations

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Washington, District of Columbia, United States and 106 other locations

COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...

Invitation-only
COVID-19
COVID Long-Haul
Other: Magnetic Resonance Imaging
Other: Ultra-High Resolution Computed Tomography (CT) Scan
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

Silver Spring, Maryland, United States and 17 other locations

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Annapolis, Maryland, United States and 28 other locations

mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...

Active, not recruiting
Covid19
ARDS, Human
Other: Placebo
Biological: Longeveron Mesenchymal Stem Cells (LMSCs)

Phase 1

Longeveron

Baltimore, Maryland, United States and 2 other locations

Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.

Active, not recruiting
Covid19
Diagnostic Test: Nasopharyngeal swab
Diagnostic Test: Fingerstick
LumiraDx

Millersville, Maryland, United States and 6 other locations

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
COVID-19
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 5 other locations

This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...

Enrolling
SARS-CoV-2
Drug: Upamostat
Drug: Placebo (PO)

Phase 2

Henry M. Jackson Foundation for the Advancement of Military Medicine

Baltimore, Maryland, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems